Advertisement
ACRS vs CRVS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Hold and CRVS is a Buy.
Momentum Indicator for ACRS turns positive, indicating new upward trend
ACRS saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In 80 of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ACRS's RSI Oscillator exited the oversold zone, 23 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for ACRS just turned positive on October 21, 2026. Looking at past instances where ACRS's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
Following a +17.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACRS advanced for three days, in 222 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
ACRS broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ACRS entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.608) is normal, around the industry mean (3.498). P/E Ratio (-6.724) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (83.333) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. ACRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
CRVS's RSI Indicator climbs out of oversold territory
The RSI Oscillator for CRVS moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 33 of the 36 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on CRVS as a result. In 78 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for CRVS just turned positive on October 20, 2026. Looking at past instances where CRVS's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.
Following a +7.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRVS advanced for three days, in 200 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRVS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
CRVS broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CRVS entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.935) is normal, around the industry mean (3.498). P/E Ratio (-16.469) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. CRVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ACRS | CRVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 35 Fair valued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 72 | |
SMR RATING 1..100 | 98 | 97 | |
PRICE GROWTH RATING 1..100 | 48 | 57 | |
P/E GROWTH RATING 1..100 | 15 | 17 | |
SEASONALITY SCORE 1..100 | 33 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CRVS's Valuation (11) in the Pharmaceuticals Major industry is in the same range as ACRS (35) in the Pharmaceuticals Other industry. This means that CRVS’s stock grew similarly to ACRS’s over the last 12 months.
CRVS's Profit vs Risk Rating (72) in the Pharmaceuticals Major industry is in the same range as ACRS (100) in the Pharmaceuticals Other industry. This means that CRVS’s stock grew similarly to ACRS’s over the last 12 months.
CRVS's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as ACRS (98) in the Pharmaceuticals Other industry. This means that CRVS’s stock grew similarly to ACRS’s over the last 12 months.
ACRS's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as CRVS (57) in the Pharmaceuticals Major industry. This means that ACRS’s stock grew similarly to CRVS’s over the last 12 months.
ACRS's P/E Growth Rating (15) in the Pharmaceuticals Other industry is in the same range as CRVS (17) in the Pharmaceuticals Major industry. This means that ACRS’s stock grew similarly to CRVS’s over the last 12 months.
| ACRS | CRVS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 89% |
| Momentum ODDS (%) | 2 days ago 87% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 86% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 87% |
| Advances ODDS (%) | 3 days ago 82% | 2 days ago 81% |
| Declines ODDS (%) | 7 days ago 84% | 10 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 89% | 2 days ago 87% |
| Aroon ODDS (%) | 2 days ago 81% | 2 days ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACRS’s FA Score shows that 1 FA rating(s) are green while CRVS’s FA Score has 2 green FA rating(s).
- ACRS’s FA Score: 1 green, 4 red.
- CRVS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACRS’s TA Score shows that 4 TA indicator(s) are bullish while CRVS’s TA Score has 4 bullish TA indicator(s).
- ACRS’s TA Score: 4 bullish, 4 bearish.
- CRVS’s TA Score: 4 bullish, 4 bearish.
Price Growth
ACRS (@Biotechnology) experienced а +10.96% price change this week, while CRVS (@Biotechnology) price change was +15.67% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
ACRS is expected to report earnings on Feb 25, 2027.
CRVS is expected to report earnings on Mar 24, 2027.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ACRS and
Correlation & Price change
A.I.dvisor indicates that over the last year, ACRS has been closely correlated with CRVS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACRS jumps, then CRVS could also see price increases.
| Ticker / NAME | Correlation To ACRS | 1D Price Change % | ||
|---|---|---|---|---|
| ACRS | 100% | -2.12% | ||
| CRVS - ACRS | 67% Closely correlated | +0.18% | ||
| STRRP - ACRS | 52% Loosely correlated | +0.89% | ||
| QUCY - ACRS | 40% Loosely correlated | +0.98% | ||
| UFPT - ACRS | 39% Loosely correlated | -1.51% | ||
| KYTX - ACRS | 38% Loosely correlated | -1.74% | ||
More | ||||
CRVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CRVS has been closely correlated with ACRS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRVS jumps, then ACRS could also see price increases.
| Ticker / NAME | Correlation To CRVS | 1D Price Change % | ||
|---|---|---|---|---|
| CRVS | 100% | +0.18% | ||
| ACRS - CRVS | 67% Closely correlated | -2.12% | ||
| RZLT - CRVS | 42% Loosely correlated | +4.09% | ||
| AMLX - CRVS | 36% Loosely correlated | +2.32% | ||
| IMNM - CRVS | 36% Loosely correlated | -3.67% | ||
| ARDX - CRVS | 36% Loosely correlated | +2.73% | ||
More | ||||